Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Erythroblastic, Acute

Explore clinical trials studying Leukemia, Erythroblastic, Acute. Study availability and eligibility vary by location and protocol.

130 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Erythroblastic, Acute trial results

Completed

Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

NCT00121303

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • North Hampshire Hospital Basingstoke, England, United Kingdom
  • Kent and Canterbury Hospital Canterbury, England, United Kingdom
  • Medway Maritime Hospital Gillingham Kent, England, United Kingdom
  • Maidstone Hospital Maidstone, England, United Kingdom
View Trial Details
Completed

Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia

NCT01870596

Conditions
Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, +25 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States
  • Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission

NCT00002768

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States
View Trial Details
Completed

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

NCT00085709

Conditions
Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Providence Cancer Center Anchorage, Alaska, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States
View all 279 locations
View Trial Details

Related conditions